Table of Contents Author Guidelines Submit a Manuscript
International Journal of Rheumatology
Volume 2016, Article ID 9345467, 4 pages
http://dx.doi.org/10.1155/2016/9345467
Clinical Study

Impact of Anti-Inflammatory Drugs on Pyogenic Vertebral Osteomyelitis: A Prospective Cohort Study

1Infectious Diseases Unit, University Hospital R. Poincaré, APHP, Versailles Saint Quentin University, Garches, France
2Pharmacy Department, University Hospital R. Poincaré, APHP, Versailles Saint Quentin University, Garches, France
3Infectious Diseases Unit, University Hospital of Bretonneau, Denis Diderot University, Tours, France
4Rheumatology Department, University Hospital of Bretonneau, Denis Diderot University, Tours, France

Received 19 August 2016; Revised 22 September 2016; Accepted 26 September 2016

Academic Editor: Bruce M. Rothschild

Copyright © 2016 Aurélien Dinh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Grammatico, S. Baron, E. Rusch et al., “Epidemiology of vertebral osteomyelitis (VO) in France: analysis of hospital-discharge data 2002-2003,” Epidemiology and Infection, vol. 136, no. 5, pp. 653–660, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Kehrer, C. Pedersen, T. G. Jensen, and A. T. Lassen, “Increasing incidence of pyogenic spondylodiscitis: a 14-year population-based study,” Journal of Infection, vol. 68, no. 4, pp. 313–320, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. O. Murillo, A. Roset, B. Sobrino et al., “Streptococcal vertebral osteomyelitis: multiple faces of the same disease,” Clinical Microbiology and Infection, vol. 20, no. 1, pp. O33–O38, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. SPILF, “Primary infectious spondylitis and following intradiscal procedure, without prothesis. Recommendations,” Medecine et Maladies Infectieuses, vol. 37, no. 9, pp. 573–583, 2007 (French). View at Publisher · View at Google Scholar
  5. L. Bernard, A. Dinh, I. Ghout et al., “Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial,” The Lancet, vol. 385, no. 9971, pp. 875–882, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. P. D. Roelofs, R. A. Deyo, B. W. Koes, R. J. Scholten, and M. W. van Tulder, “Non-steroidal anti-inflammatory drugs for low back pain,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD000396, 2008. View at Google Scholar · View at Scopus
  7. M. Bertolotto, P. Contini, L. Ottonello, A. Pende, F. Dallegri, and F. Montecucco, “Neutrophil migration towards C5a and CXCL8 is prevented by non-steroidal anti-inflammatory drugs via inhibition of different pathways,” British Journal of Pharmacology, vol. 171, no. 14, pp. 3376–3393, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Voiriot, S. Dury, A. Parrot, C. Mayaud, and M. Fartoukh, “Nonsteroidal antiinflammatory drugs may affect the presentation and course of community-acquired pneumonia,” Chest, vol. 139, no. 2, pp. 387–394, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. P. François, A. Desrumaux, C. Cans, I. Pin, P. Pavese, and J. Labarère, “Prevalence and risk factors of suppurative complications in children with pneumonia,” Acta Paediatrica, vol. 99, no. 6, pp. 861–866, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Souyri, P. Olivier, S. Grolleau, and M. Lapeyre-Mestre, “Severe necrotizing soft-tissue infections and nonsteroidal anti-inflammatory drugs,” Clinical and Experimental Dermatology, vol. 33, no. 3, pp. 249–255, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Guibal, M. Muffat-Joly, B. Terris, L. Garry, P. Morel, and C. Carbon, “Effects of diclofenac on experimental streptococcal necrotizing fasciitis (NF) in rabbit,” Archives of Dermatological Research, vol. 290, no. 11, pp. 628–633, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. G. A. Spinas, D. Bloesch, U. Keller, W. Zimmerli, and S. Cammisuli, “Pretreatment with ibuprofen augments circulating tumor necrosis factor-α, interleukin-6, and elastase during acute endotoxinemia,” Journal of Infectious Diseases, vol. 163, no. 1, pp. 89–95, 1991. View at Publisher · View at Google Scholar · View at Scopus